4-乙基-3,4-二氢-2(1H)-喹喔啉酮 | 90917-94-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 4-乙基-3,4-二氢-2(1H)-喹喔啉酮
• 中文别名: 2(1H)-喹喔啉酮,4-乙基-3,4-二氢-
• 英文名称: 4-ethyl-1,2,3,4-tetrahydroquinoxalinone-2
• 英文别名: 4-ethyl-3,4-dihydro-1H-quinoxalin-2-one；4-Aethyl-3,4-dihydro-1H-chinoxalin-2-on；4-Ethyl-3,4-dihydroquinoxalin-2(1H)-one；4-ethyl-1,3-dihydroquinoxalin-2-one
• CAS: 90917-94-5
• 化学式: C₁₀H₁₂N₂O
• mdl: MFCD00957214
• 分子量: 176.218
• InChiKey: UHWCUWHJCAXFJR-UHFFFAOYSA-N

物化性质

• 熔点：
  112-114 °C
• 沸点：
  352.9±35.0 °C(Predicted)
• 密度：
  1.119±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-乙基-3,4-二氢-2(1H)-喹喔啉酮 在 lithium aluminium tetrahydride 、 乙醚 作用下， 生成 4-乙基-2,3-二氢-1H-喹喔啉
  参考文献：
  名称：

  Convenient Syntheses of 1,2,3,4-Tetrahydroquinoxalines

  摘要：

  DOI：

  10.1021/jo01084a014
• 作为产物：
  描述：

  溴乙烷 、 3,4-二氢-1H-喹噁啉-2-酮 在 potassium carbonate 作用下， 以 甲醇 为溶剂， 反应 25.0h， 以67%的产率得到4-乙基-3,4-二氢-2(1H)-喹喔啉酮
  参考文献：
  名称：

  A Novel Application of Heterocyclic Compounds for Biosensors Based on NAD, FAD, and PQQ Dependent Oxidoreductases

  摘要：

  Various five-, six-, and seven-membered heterocyclic compounds containing two nitrogen atoms as well as quinoid substances were synthesized and investigated. Electrochemical oxidation-polymerization of these heterocycles on carbon and platinum electrodes was performed in aqueous medium. Electrochemically pre-treated carbon electrodes modified with these heterocyclic compounds and were used for the electro-catalytic oxidation of NADH and for the design of mediated glucose biosensors.

  DOI：

  10.1007/pl00010188

文献信息

• COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
  申请人：CHATTERJEE Arnab Kumar

  公开号：US20150291598A1

  公开（公告）日：2015-10-15

  The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease, such as malaria, caused by a Plasmodium parasite.

  本发明提供了I式化合物：[插入公式]或其药学上可接受的盐、互变异构体或立体异构体，其中变量的定义如本文所述。本发明还提供了包含这种化合物的药物组合物以及使用这种化合物治疗、预防、抑制、改善或根除由疟原虫引起的疾病，如疟疾的病理学和/或症状学的方法。
• Covalent inhibitors of KRas G12C
  申请人：Araxes Pharma LLC

  公开号：US10919850B2

  公开（公告）日：2021-02-16

  Irreversible inhibitors of G12C mutant K-Ras protein are provided. Also disclosed are methods to modulate the activity of G12C mutant K-Ras protein and methods of treatment of disorders mediated by G12C mutant K-Ras protein.

  提供了 G12C 突变 K-Ras 蛋白的不可逆抑制剂。还公开了调节 G12C 突变体 K-Ras 蛋白活性的方法和治疗由 G12C 突变体 K-Ras 蛋白介导的疾病的方法。
• van Romburgh; Deys, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, Series B: Physical Sciences, 1931, vol. 34, p. 1004
  作者：van Romburgh、Deys

  DOI：——

  日期：——
• PROCESS FOR THE PREPARATION OF TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS FOR USING THE SAME FOR THE TREATMENT OF CANCER
  申请人：Genentech, Inc.

  公开号：US20210253599A1

  公开（公告）日：2021-08-19

  The present disclosure provides for methods for preparing tricyclic PI3K inhibitor compounds in high yield and purity in aqueous solvent systems.
• US7262186B2
  申请人：——

  公开号：US7262186B2

  公开（公告）日：2007-08-28